Since the arrival of the deadly virus, there has been a lot happening to our country. Starting with the economy of Kenya being worse than ever in history. All this has led to an even shortage of ARVS in the country the only drug that helps the positive victims of HIV and AIDs.
"HIV patients are in distress following acute shortage of ARVs. The drugs are stuck at the port as the government has slapped sh90m tax on the consignment that's supposed to be distributed for free by donors because they bypassed corruption-ridden KEMSA. Don't punish the sick!" Millicent Omanga states.
The controversial senator says it's the government fault to be having a shortage of ARVS in the country. A few weeks back one of the victims of HIV and AIDs complained that they are having a shortage of drugs as they used to take a 3months dose and now it's reduced to two weeks dose or one month.
Below is the section of Kenyans recating on the same.
Content created and supplied by: Ariana-news (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More